Acumen Pharmaceuticals ABOS Income Statement (2020-2026)

NASDAQ ABOS
$2.24 -0.06 (-2.39%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Acumen Pharmaceuticals Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

Acumen Pharmaceuticals reported net income of -$32.54M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
40.47M20.06M40.47M40.50M40.50M41.03M41.03M41.03M57.91M57.91M60.08M60.08M60.08M60.09M60.57M60.57M60.57M60.58M72.23M72.31M
Operating items
Research & DevelopmentR&D
1.80M5.67M5.99M7.32M8.31M10.75M8.71M9.13M11.18M13.29M12.45M19.53M27.25M34.57M25.27M37.12M21.97M20.53M16.48M27.81M
Selling, General & AdministrativeSG&A
2.13M2.74M3.22M3.09M3.06M3.50M4.42M4.34M4.86M5.19M5.33M4.85M5.02M5.03M5.10M4.62M4.54M4.67M4.67M4.75M
Operating ExpensesOpex
3.94M8.41M9.21M10.41M11.37M14.25M13.13M13.48M16.04M18.49M17.77M24.38M32.27M39.60M30.37M41.75M26.51M25.20M21.15M32.56M
Operating IncomeOp. Inc
-3.94M-8.41M-9.21M-10.41M-11.37M-14.25M-13.13M-13.48M-16.04M-18.49M-17.77M-24.38M-32.27M-39.60M-30.37M-41.75M-26.51M-25.20M-21.15M-32.56M
EBIT
-3.94M-8.41M-9.21M-10.41M-11.37M-14.25M-13.13M-13.48M-16.04M-18.49M-17.77M-24.38M-32.27M-39.60M-30.37M-41.75M-26.51M-25.20M-21.15M-32.56M
Non-operating items
Non Operating Interest Expenses
0.02M0.58M1.00M1.00M1.03M1.04M1.02M1.05M1.07M1.09M1.07M1.09M
Interest & Investment IncomeInt & Inv Inc
0.04M1.88M3.12M3.95M4.00M3.82M3.50M2.99M2.47M2.02M1.64M1.32M1.06M1.11M
Other Non Operating IncomeOther Non Op Inc.
0.02M0.00M0.00M-0.00M-0.01M-0.00M-0.02M-0.04M-1.30M-0.05M1.10M0.03M0.55M0.19M-0.13M-0.44M-0.17M0.46M-0.16M
Non Operating IncomeNon Op. Inc.
0.03M0.07M0.08M0.26M0.66M1.38M1.83M1.87M3.08M1.99M2.90M3.84M2.50M2.44M1.57M0.80M0.06M0.06M0.41M-0.16M
Net income details
EBT
-3.92M-8.41M-9.21M-10.41M-11.37M-14.25M-13.13M-11.59M-12.91M-15.12M-14.77M-21.57M-29.79M-37.64M-28.92M-40.78M-25.94M-24.96M-21.15M-32.54M
Profit After TaxPAT
-3.92M-8.41M-9.21M-10.41M-11.37M-14.25M-13.13M-11.59M-12.91M-15.12M-14.77M-21.57M-29.79M-37.64M-28.92M-40.78M-25.94M-24.96M-21.15M-32.54M
Income from Continuing OperationsIncome (Continuing)
-3.92M-8.41M-9.21M-10.41M-11.37M-14.25M-13.13M-11.59M-12.91M-15.12M-14.77M-21.57M-29.79M-37.64M-28.92M-40.78M-25.94M-24.96M-21.15M-32.54M
Consolidated Net IncomeConsol Net Inc.
-3.92M-8.41M-9.21M-10.41M-11.37M-14.25M-13.13M-11.59M-12.91M-15.12M-14.77M-21.57M-29.79M-37.64M-28.92M-40.78M-25.94M-24.96M-21.15M-32.54M
Income towards Parent CompanyParent Net Inc
-3.90M-8.35M-9.13M-10.15M-10.71M-12.87M-11.31M-11.61M-12.96M-16.50M-14.87M-20.54M-29.77M-37.15M-28.80M-40.95M-26.45M-25.14M-20.74M-32.72M
Net Income towards Common StockholdersNet Income
-3.90M-8.35M-9.13M-10.15M-10.71M-12.87M-11.31M-11.61M-12.96M-16.50M-14.87M-20.54M-29.77M-37.15M-28.80M-40.95M-26.45M-25.14M-20.74M-32.72M
Additional items
EPS (Basic)
-0.10-0.42-0.23-0.25-0.26-0.32-0.28-0.28-0.24-0.34-0.25-0.34-0.50-0.62-0.48-0.68-0.44-0.42-0.33-0.45
EPS (Diluted)
-0.10-0.42-0.23-0.25-0.26-0.32-0.28-0.28-0.24-0.34-0.25-0.34-0.50-0.62-0.48-0.68-0.44-0.42-0.33-0.45
Shares Outstanding
38.27M20.06M40.47M40.50M40.50M40.60M41.03M41.03M54.23M48.61M59.81M60.08M60.08M60.01M60.53M60.57M60.57M60.56M63.22M72.25M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
38.27M20.06M40.47M40.50M40.50M40.60M41.03M41.03M54.23M48.61M59.81M60.08M60.08M60.01M60.53M60.57M60.57M60.56M63.22M72.25M
EBITDA
-8.41M-9.20M-10.40M-11.36M-14.24M-13.12M-13.46M-16.03M-18.47M-17.76M-24.36M-32.25M-39.58M-30.36M-41.73M-26.50M-25.19M-21.14M-32.55M
Interest ExpensesInt Expense
0.02M0.58M1.00M1.00M1.03M1.04M1.02M1.05M1.07M1.09M1.07M1.09M

Acumen Pharmaceuticals Income Statement API

Pull Acumen Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ABOS&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY